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Background: In the immune system, the serum levels of immunoglobulin (Ig) increase gradually during ageing.
Through B cell development, the Ig heavy chain expression is modulated by a regulatory region at the 3’ of the
constant alpha gene (3’RR), in single copy in rodents and, due to a large duplication, in two copies in apes. The
human 3’RR1 and 3’RR2 are both characterized by three enhancers, the central of which, namely hs1.2, is highly
polymorphic. Human hs1.2 has four different variants with unique binding sites for transcription factors (e.g. NF-kB
and SP1) and shows variable allelic frequencies in populations with immune disorders. In previous works, we have
reported that in several autoimmune diseases the *2 allele of hs1.2 is genetically associated to high level of IgM in
peripheral blood. In subjects with altered levels of circulating Ig, an increased level was associated to *2 allele of
hs1.2 and low levels corresponded to high frequency of *1 allele.
During ageing there is a physiological increase of Ig concentrations in the serum. Therefore, for this study, we
hypothesized that the hs1.2 variants may impact differently the levels of secreted Ig during the growth.
Results: We have correlated the allelic frequencies of hs1.2 with IgM, IgG and IgA serum concentrations in two
cohorts of healthy people of different age and after three years follow-up in children homozygous for the allele.
Here we show that when the expression levels of Ig in children are low and medium, the frequencies of *1 and *2
alleles are the same. Instead, when the Ig expression levels are high, there is a significantly higher frequency of
the allele *2. The follow-up of children homozygous for *1 and *2 alleles showed that the increase or decrease of
circulating Ig was not dependent on the number of circulating mature B cells.
Conclusions: These data support the idea that under physiologic condition there is a switch of regulative pathways
involved in the maturation of Ig during ageing. This mechanism is evidenced by hs1.2 variants that in children but
not in adults participate to Ig production, coordinating the three class levels.
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The serum levels of Immunoglobulins (Ig) are the result
of regulated processes involving B cell development and
the progressive expression of immunoglobulin heavy chain
(Igh) genes [1]. During B cell differentiation, IgH locus
(14q32.33) undergoes various DNA rearrangements and
epigenetic changes, necessary for the generation of anti-
body repertoire [2-5].
The regulatory region 3′RR at the 3′ of the constant
alpha gene is in single copy in rodents and in two copies in
apes due to a large duplication described in Figure 1 [6].
The human IgH locus is characterized by two 3′ regu-
latory regions (3′RR) caused by a duplication, both
downstream with respect to heavy chain alpha (Cα)
genes (see Figure 1). Each 3′RR is composed of three
different enhancers. In both cases the central enhancer
hs1.2 is located in one region with a palindromic se-
quence conserved in structure but not in sequence [7-9]
and contains a 40-bp tandem-repeat DNA motif, poly-
morphic for number of copies and conserved in different
species of mammals [10,11]. In humans this 40 bp re-
gion is repeated from one to four times. The hs1.2 allele
with two copies of 40 bp element is called allele *2 and
carries a unique binding site for NF-κB transcription fac-
tor [12]. In the machinery of the Ig maturation the class
switches when IgG2, IgG4, IgA2 and IgE are produced.
Since 3′RR1 is deleted along with the rest of the heavy
chain involved in the excision, the switched allele will be
under the control of the 3′RR2. Of note, more then 95%Figure 1 hs1.2 location and known human variants. a) The locus of the
The three enhancers of 3′RR1 and 3′RR2 are conserved in order: hs3 (orang
inverted in 3′RR2 with respect to the 3′RR1. b) Regulatory regions at the 3′
repeats is shown in violet, while the palindromic regions in light blue. c) Sc
(see included caption box for colors explanation).of human subjects bear *4 allele of hs1.2 in 3′RR2 giving
a high homogeneity of the expression and not the variabil-
ity observed for 3′RR1 (see Figure 1). Different selective
advantages or disadvantages are related to possible differ-
ent functions. Hs1.2 allele *2 in the distal 3′RR1 is signifi-
cantly more frequent in patients with several autoimmune
diseases, such as celiac disease, psoriasis, systemic scler-
osis, rheumatoid arthritis, and lupus erythematosus with
respect to healthy control group [12-15], and is associated
with high levels of IgM in peripheral blood [16]. Of note,
patients with IgA deficiency show a significant correlation
with hs1.2 allele *1 [16]. Finally, new evidence have been
reported on the differences among hs1.2 polymorphic var-
iants indicating complex interactions between binding fac-
tors and enhancers after stimulation of mouse and human
B cells [17].
It has already been described that follow-up of chil-
dren through adulthood shows a gradual increase of Ig
concentrations in serum [1]. Therefore, in order to de-
termine if there is a genetic correlation between hs1.2 al-
leles and the levels of circulating Ig in children and
adults, we compared the concentration of circulating Ig
in association with allelic frequency of hs1.2 enhancer in
one cohort of adults and one of young healthy subjects.
Our data show that the IgM, IgG and IgA serum con-
centrations are significantly associated with the hs1.2 al-
leles in youth, but not in adult population, suggesting a
fundamental role of hs1.2 enhancer variants in the Ig ex-
pression in children.Ig heavy chain with the variable, constant and regulatory elements.
e), hs1.2 (rainbow), hs4 (dark green). Nevertheless, hs1.2 sequence is
of the constant alpha1 and alpha2 genes (blue). A 20 bp conserved
heme of the six variants of the enhancer hs1.2 known in human
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One cohort of healthy children and one of adults were
recruited and measured for the Ig serum levels. Indi-
viduals were divided in three groups with low, medium
and high serum levels with respect to the Ig median of
each cohort (Additional file 1: Table S1 and in the
Methods). The Ig levels were all in the normal range.
Table 1A-B shows the allelic frequencies for both co-
horts within each Ig class and reports that hs1.2 alleles
are associated with Ig serum levels in children, but not
in adults (Additional file 2: Figure S1 dot-plots the data
summarized in both Table 1 and Additional file 1: Table
S1). In fact, the comparison of Low (L) vs High (H) and
Medium (M) vs H serum levels of Ig shows highly signifi-
cant different allelic frequencies (constantly p < 9.9E-08),
only in the population of children. Similar variations of *1
and *2 allele frequencies in children were observed in each
Ig class of young cohort: the *1 allele frequency decreases
from the range of 41%-49% in L and M groups to the
range of 2%-5% in H group and, on the contrary, *2 allele
frequency increased from the range of 39%-49% in L and
M groups to the range of 79%-82% in H group. It is re-
markable that no young subjects homozygous for *1 allele
were included in the H groups of IgM and IgG, and only
one young subject was present in the H group of IgA. The
frequencies of 2/2 homozygous genotype in children of L
and M groups were between 1.7%-13.3%, while the H
group of each Ig class was comprised between 60.0%-
66.6%. In children and adults, the medians of Ig level
were very similar, in agreement with the ranges re-
ported in literature [1] (see Additional file 1: Table
S1). Nevertheless, the adult cohort did not show the sameTable 1 Allelic frequencies of hs1.2 enhancer in children (A) a
A IgM IgG
Low Medium High Low
Children (f) ALLELE 1 0.47 ± 0.03 0.44 ± 0.04 0.02 ± 0.01 0.48 ±
ALLELE 2 0.43 ± 0.04 0.46 ± 0.04 0.81 ± 0.04 0.44 ±
ALLELE 3 0 0 0 0
ALLELE 4 0.1 ± 0.03 0.1 ± 0.02 0.17 ± 0.03 0.08 ±
n. 60 70 60 60
B
Adults (f) ALLELE 1 0.29 ± 0.03 0.32 ± 0.03 0.25 ± 0.02 0.30 ±
ALLELE 2 0.56 ± 0.04 0.54 ± 0.02 0.58 ± 0.03 0.54 ±
ALLELE 3 0 0.01 ± 0.01 001 ± 0.01 0.01 ±
ALLELE 4 0.15 ± 0.01 0.13 ± 0.02 0.16 ± 0.01 0.15 ±
n. 110 120 110 110
(A) pValue IgM LOW vs HIGH = 3.9E-12; LOW vs MEDIUM = 8E-04; MEDIUM vs HIGH
MEDIUM vs HIGH = 9.9E-08; pValue IgG LOW vs HIGH = 8.3E-11; LOW vs MEDIUM = 1
(B) pValue IgM LOW vs HIGH = 0.92; LOW vs MEDIUM = 0.97; MEDIUM vs HIGH = 0.7
HIGH = 0.99; pValue IgA LOW vs HIGH 0.14; LOW vs MEDIUM 0.11; MEDIUM vs HIGH
(n. = Number of subjects).level and significance of allelic frequency variations than
children when subdivided for Ig levels in L, M, and H
groups (Table 1A; 0.69 < p < 0.92). Consequently the prob-
ability of one subject to be in one group of Ig level and also
in the same group for the other Ig classes is very high in
children, but not in adults (see Additional file 1: Table S2).
The genetic association between Ig concentrations and
hs1.2 polymorphism suggests likely age-related changes in
Ig expression for children homozygous for *1 or *2 allele.
Therefore, we followed up the Ig levels of those children
for three years. As reported in Table 2, after three years
(from five to eight) *1 allele homozygous children showed
an increase of IgG and IgA levels, while *2 allele homozy-
gous children showed a decrease in all Ig levels. We also
investigated if B cell subpopulations of peripheral blood
were similar in two homozygous groups by flow cytomet-
ric analysis, using IgM and IgD surface cell markers for
the distribution of naive, marginal zone, IgM memory and
switched memory B cells (Additional file 1: Table S3).
Children homozygous for *1 and *2 alleles show no differ-
ences in the distribution of B cell subtypes, suggesting
moreover that the number of B subtypes of circulating
cells does not influence IgM concentration in individual
with different genotype (Additional file 1: Table S3).
Previous evidence showed the association of Ig levels
with 3′RR1 enhancer hs1.2 polymorphism in auto-
immune diseases. In these experiments we studied the
role of hs1.2 polymorphism in physiological condi-
tions in healthy subjects. Our results show that in
children there is a significant correlation between dif-
ferent hs1.2 alleles and Ig expression levels, suggesting
that hs1.2 polymorphism might primarily influencend adults (B) divided for the serum levels of Ig
IgA
Medium High Low Medium High
0.05 0.41 ± 0.04 0.05 ± 0.02 0.49 ± 0.04 0.40 ± 0.06 0.05 ± 0.03
0.03 0.47 ± 0.06 0.79 ± 0.04 0.39 ± 0.05 0.49 ± 0.04 0.82 ± 0.03
0 0 0 0 0
0.02 0.12 ± 0.03 0.16 ± 0.03 0.12 ± 0.03 0.11 ± 0.03 0.13 ± 0.02
70 60 60 70 60
0.02 0.30 ± 0.02 0.26 ± 0.02 0.34 ± 0.03 0.26 ± 0.04 0.27 ± 002
0.04 0.55 ± 0.06 0.58 ± 0.04 0.52 ± 0.04 0.58 ± 0.03 0.57 ± 0.07
0.01 0.01 ± 0.01 0.01 ± 0.01 0.01 ± 0.01 0 0.01 ± 0.01
0,01 0.14 ± 0.01 0.16 ± 0.02 0.13 ± 0.03 0.16 ± 0.01 0.15 ± 0.02
120 110 110 120 110
= 5.2E-10; pValue IgA LOW vs HIGH = 5.6E-11; LOW vs MEDIUM = 1E-03;
E-03; MEDIUM vs HIGH = 4.6E-08.
9; pValue IgG LOW vs HIGH = 0.53; LOW vs MEDIUM = 0.61; MEDIUM vs
0.79.
Table 2 Ig median follow-up from 5 to 8 years
IgM median IgG median IgA median













1/1 10 98.5 ± 0.07 94.5 ± 0.05 4.94E-01 880.5 ± 0.12 1029.5 ± 0.14 1.31E-01 86.5 ± 0.04 102 ± 0.06 9.86E-02
2/2 30 217.5 ± 0.11 103 ± 0.09 1.09E-11 1674.5 ± 0.16 979 ± 0.13 1.98E-13 208 ± 0.12 105.5 ± 0.08 1.29E-13
Follow-up of Ig concentrations in children homozygous for hs1.2 *1 and *2 alleles.
The children cohort (5 years old as median) was tested at time 0 and three years later. The t test shows a high significance for all the differences in the Ig median
levels of 2/2 homozygous children, whereas the differences in 1/1 children were always not significant.
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hood. Moreover the follow-up of the children homo-
zygous for the *1 allele showed that, after the fifth year
of age, the Ig median values for all three classes in-
crease; instead, in subjects homozygous for the *2 al-
lele the values strongly decrease. This trend leads to
the final adult equilibrium observed where no correl-
ation is shown with Ig levels and hs1.2 alleles.Conclusions
Our data imply that during physiological development
there is a switch of regulatory mechanisms involved in
Ig expression that might be reverted in autoimmune
diseases [12-14]. The similar distribution of B cells
subpopulations in homozygous children for *1 and *2
alleles (most frequent in European populations) sug-
gests that the different Ig levels are obtained by differ-
ent Ig secretion of the cells and not by the different
number of B cells.
In conclusion we like assessing that there is a mechan-
ism, correlated to hs1.2 polymorphism, that in children
leads to a parallel control of IgA, IgG and IgM, while in
adulthood changes to produce the three Ig classes at dif-
ferent concentrations.
These observations raise the possibility that in chil-
dren the polymorphism of the hs1.2 enhancer is a rele-
vant component in regulatory mechanism involved in
Ig expression. The presence in Europe of higher *2
allele [18] and these results related to Ig levels in chil-
dren can give an explanation for the selective advan-
tage of the allele balanced by the disadvantage in
adulthood for the association to autoimmune disease.
It must be mentioned that in humans the presence of
two copies of hs1.2 derived by the duplication of the
3′RR can give the possibility to the alleles of the first
copy at 3′ of alpha-1 to influence the regulation other-
wise absent if the gamma 2/4, epsilon and alpha-2
switch occurs.
Moreover this evidence answers the question about
the function of the alleles. In fact, the positive associ-
ation of *2 allele with high Ig levels in childhood could
be the reason for the positive selection after themigration out of Africa: a condition of shorter life ex-
pectancy could have led to a reduced risk for immune-
diseases development.
Nevertheless, further studies will be required to ad-
dress the role of hs1.2 during aging.Methods
The cohort of healthy children was composed of 190
subjects (88 females and 102 males; age range 3–5
years; median age 3.75 years). A second cohort of 340
adult subjects consisted of 218 females (64%) and 122
males (36%) and with an age range from 19 to 33 years
(median age 24 years). Research was carried out in
compliance with the Helsinki Declaration and the
study was approved by the Ethics Committee of
Fondazione IRCCS Ca’ Granda Ospedale Maggiore
Policlinico in Milan, Italy. The parents of all of the
participants gave their written informed consent. From
each individual, genomic DNA was extracted from
blood by standard methods and a selective PCR for 3′
RR1 region containing the polymorphic hs1.2 alleles
was performed by conditions previously described
[11]. The frequencies of four hs1.2 alleles detected in
two cohorts were evaluated by standard chi-square
tests. The median value of Ig concentration of each
cohort was used to get an equal number of subjects
with low and high Ig levels, the group with medium
level contained the remaining subjects. The range of
Ig levels of each sub-group resulted as the minimum
and maximum value of the subjects in that sub-group
as a consequence of the subdivision determined by the
median of the entire cohort. The dosage of Ig is mg/
dl. The subjects were then classified arbitrarily by
IgM, IgG and IgA serum concentrations (Low [L],
Medium [M], and High [H]) respect to the median
value and by age, children (<5 y/o) and adults (>19 y/o),
as shown in Table 1A-B. All the subjects had Ig values
within the normal range concentrations. Finally, fifty μl of
whole blood was labeled as well by 6-color TBNK™ kit
reagent (BD Biosciences), according to manufacturer’s
recommendations for quantification and follow up of
CD19+ cells.
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Additional file 1: Table S1. Ig levels range and median of the Low/
Medium/High subcohorts. Table S2. The % of subjects with the same
level of Ig for the three classes. Table S3. Markers of B cells in children
homozygous for 3′RR1 hs1.2 allele.
Additional file 2: Figure S1. Dot-plot of the data summarized in
Table 1; hs1.2 alleles detected in each subject are on the x-axis, and Ig
level detected in the same subject on the y-axis. Red lines represent the
Low/Medium and Medium/High Ig-expression limits, as reported in
Additional file 1: Table S1.
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